ASN Publications, KIReports, NDT, NephroPOCUS, and clinicians highlight CKD guideline implementation, SGLT2 use, QT-prolonging meds in CKD, and diagnostic imaging pearls as a multi-post theme.
The dramatic expansion in CKD therapeutics to prevent progression of kidney disease
SGLT2-inhibitors in Adult Patients With #Alport Syndrome
QT-prolonging medications: prevalence of use and associated risks in CKD
Very interesting #echofirst image.
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Healthcare